{"id":756,"date":"2020-10-04T10:07:24","date_gmt":"2020-10-04T01:07:24","guid":{"rendered":"http:\/\/www.emukk.com\/WP\/?p=754"},"modified":"2020-10-05T14:14:38","modified_gmt":"2020-10-05T05:14:38","slug":"biomarker-research-using-pancreatic-duct-adenocarcinoma-derived-organoids","status":"publish","type":"post","link":"https:\/\/www.emukk.com\/WP\/en\/biomarker-research-using-pancreatic-duct-adenocarcinoma-derived-organoids\/","title":{"rendered":"Biomarker research for pancreatic duct adenocarcinoma using its organoids"},"content":{"rendered":"

A group of Harvard Medical Schools has reported potential biomarkers for pancreatic duct adenocarcinoma using pancreatic duct adenocarcinoma derived organoids.<\/p>\n

https:\/\/insight.jci.org\/articles\/view\/135544<\/a><\/p>\n

(1) From the viewpoint of glycans: High mannose and Lewis X epitope structures increase in pancreatic duct adenocarcinoma.<\/p>\n

(2) From the viewpoint of extracellular vesicles (EV) proteins: ANXA11 (anexine A11: calcium-dependent phospholipid binding protein mobilized in the budding region of the transport endoplasmic reticulum COPII of the endoplasmic reticulum) is increased.<\/p>\n

Let’s look forward to further research progress.<\/p>\n","protected":false},"excerpt":{"rendered":"

A group of Harvard Medical Schools has reported potential biomarkers for pancreatic duct adenocarcinoma using <\/p><\/div>\n

\u7d9a\u304d\u3092\u8aad\u3080<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[70,7],"tags":[],"class_list":["post-756","post","type-post","status-publish","format-standard","hentry","category-nature-en","category-technology-en"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t